PIM
AERI

Partner Investment Management’s Aerie Pharmaceuticals AERI Stock Holding History

Partner Investment Management’s Portfolio AERI Stock Details AERI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		$436K Buy
18,035
+1,304
+8% +$27K 3.13% 14
2019
Q3 		$322K Buy
+16,731
New +$383K 0.55% 50
2019
Q1 		– Sell
-22,559
Closed -$814K – 118
2018
Q4 		$814K Sell
22,559
-4,005
-15% -$188K 1.02% 35
2018
Q3 		$1.64M Sell
26,564
-8,016
-23% -$515K 1.25% 28
2018
Q2 		$2.34M Sell
34,580
-1,891
-5% -$106K 1.89% 12
2018
Q1 		$1.98M Buy
36,471
+2,783
+8% +$156K 2.14% 13
2017
Q4 		$2.01M Buy
33,688
+1,986
+6% +$120K 2.32% 11
2017
Q3 		$1.54M Sell
31,702
-794
-2% -$43.3K 1.46% 24
2017
Q2 		$1.71M Buy
32,496
+5,207
+19% +$242K 2.29% 14
2017
Q1 		$1.24M Sell
27,289
-4,557
-14% -$203K 1.51% 25
2016
Q4 		$1.21M Sell
31,846
-10,592
-25% -$401K 1.6% 23
2016
Q3 		$1.6M Sell
42,438
-1,907
-4% -$42.1K 2.37% 9
2016
Q2 		$780K Sell
44,345
-2,720
-6% -$44K 1.28% 35
2016
Q1 		$572K Sell
47,065
-2,491
-5% -$39.4K 0.93% 34
2015
Q4 		$1.21M Sell
49,556
-170
-0.3% -$3.97K 1.98% 19
2015
Q3 		$882K Buy
49,726
+6,103
+14% +$111K 1.33% 27
2015
Q2 		$770K Buy
43,623
+37,856
+656% +$694K 1.08% 38
2015
Q1 		$181K Buy
+5,767
New +$167K 0.27% 75

Other funds holding AERI

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
FCMI
Foresite Capital Management III Larkspur, California $37.9M AUM 6.87% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
LCS
Levin Capital Strategies New York $1.49B AUM 30.44% 1-Year Est. Return
FCMI
Foresite Capital Management II Larkspur, California $29.2M AUM 44.84% 1-Year Est. Return
FCMI
Foresite Capital Management IV Larkspur, California $237M AUM 107.53% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Partner Investment Management's AERI Position: Q4 2019 in Review

Partner Investment Management increased its Aerie Pharmaceuticals (AERI) stake by 7.8% in Q4 2019, buying an estimated $27K and bringing the position to 18,035 shares worth $436K. The position accounts for 3.13% of the portfolio, ranked #14.

Partner Investment Management first reported a position in AERI in Q1 2015 and has held it in 18 quarters since. The position peaked at $2.34M in Q2 2018. 167 funds tracked by Wall St. Rank hold AERI as of Q4 2019.

  • Partner Investment Management held 18,035 shares of Aerie Pharmaceuticals worth $436K as of Q4 2019.
  • Partner Investment Management bought 1,304 Aerie Pharmaceuticals shares in Q4 2019, an estimated $27K.
  • Aerie Pharmaceuticals made up 3.13% of Partner Investment Management's portfolio in Q4 2019, its #14 holding.
  • Partner Investment Management first reported a position in Aerie Pharmaceuticals in Q1 2015 and has held it in 18 quarters since.
  • Partner Investment Management's Aerie Pharmaceuticals position peaked at $2.34M in Q2 2018.
  • 167 funds tracked by Wall St. Rank held Aerie Pharmaceuticals as of Q4 2019.

Based on Partner Investment Management's 13F filing for Q4 2019, filed 14 Feb 2020.